Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BCC 2025 | Managing radiotherapy induced arm swelling in breast cancer

Tim Rattay • 13 Mar 2025
BCC 2025
Breast Cancer

Tim Rattay, MBChB, PhD, FRCS, University of Leicester, Leicester, UK, comments on the importance of supportive measures for patients at higher risk of arm swelling. The development of a patient-facing app will provide personalized risk assessment and offer supportive measures such as weight loss, exercises, and the use of an arm sleeve or stockinette to reduce the risk of long-term arm lymphedema. This interview took place at the 2025 St. Gallen International Breast Cancer Consensus Meeting in Vienna, Austria.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Tim Rattay

The future of patient apps in breast cancer management
1:55
The future of patient apps in breast cancer management
Tim Rattay • 13 Mar 2025
PRE-ACT-01: AI-based risk prediction for RT-induced lymphoedema
0:45
PRE-ACT-01: AI-based risk prediction for RT-induced lymphoedema
Tim Rattay • 13 Mar 2025
The future of AI in managing breast cancer
1:31
The future of AI in managing breast cancer
Tim Rattay • 18 Mar 2024
Creating an AI prediction model for arm lymphedema in breast cancer
2:56
Creating an AI prediction model for arm lymphedema in breast cancer
Tim Rattay • 18 Mar 2024

Related Videos

ASCENT-04: PFS2 with sacituzumab govitecan and pembrolizumab in PD-L1+ mTNBC
1:12
ASCENT-04: PFS2 with sacituzumab govitecan and pembrolizumab in PD-L1+ mTNBC
Kevin Kalinsky • 31 May 2026
Clinical relevance of PFS2 in metastatic triple-negative breast cancer
1:10
Clinical relevance of PFS2 in metastatic triple-negative breast cancer
Kevin Kalinsky • 31 May 2026
Genomic assays and chemotherapy decisions in node-positive breast cancer
1:35
Genomic assays and chemotherapy decisions in node-positive breast cancer
Kevin Kalinsky • 31 May 2026
ASCENT-07: SG in patients with HER2 IHC0 HR+/HER2- breast cancer
1:30
ASCENT-07: SG in patients with HER2 IHC0 HR+/HER2- breast cancer
Yeon Hee Park • 31 May 2026
The content of VJOncology is intended for healthcare professionals